PodcastSleep Medicine
Briefing Chat: New narcolepsy drug could unlock host of novel brain therapies
Aug 21, 2026
Nature staff discuss how a newly approved orexin-targeting narcolepsy drug could enable therapies for other neurological conditions, and examine human brain organoids that have remained viable for more than five years. The episode connects sleep medicine, therapeutic neuroscience, and long-term models of human brain development.
SeminarNeuroscience
Neurobiology of Narcolepsy: effects of the oxytocin system on cataplexy
Carrie Mahoney
Harvard Medical School
Dec 13, 2021